U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDA Rx Reminder Ads and Reminder Labeling - Name-Only Exemption

A reminder piece may skip risk information only if it calls attention to the product name with permitted factual items and no representations, and reminders are not available for drugs with a boxed warning.

21 CFR 202.1(e)(2)(i); 21 CFR 201.100(f)

What is FDA Rx Reminder Ads and Reminder Labeling - Name-Only Exemption?

A reminder piece may skip risk information only if it calls attention to the product name with permitted factual items and no representations, and reminders are not available for drugs with a boxed warning. Apply to name-only prescription drug ads, reminder labeling, promotional items and short digital units without risk information.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

What does this rule require?

A reminder piece may skip risk information only if it calls attention to the product name with permitted factual items and no representations, and reminders are not available for drugs with a boxed warning.

How can marketing teams comply?

Apply to name-only prescription drug ads, reminder labeling, promotional items and short digital units without risk information.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 CFR 202.1(e)(2)(i); 21 CFR 201.100(f)
Published
2026-11-16
Effective date
2026-10-07
Channel
all_channels
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, health_professionals, patients

Frequently asked questions

What is FDA Rx Reminder Ads and Reminder Labeling - Name-Only Exemption?

A reminder piece may skip risk information only if it calls attention to the product name with permitted factual items and no representations, and reminders are not available for drugs with a boxed warning.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan